当前位置:首页 - 行情中心 - 贝瑞基因(000710) - 财务分析 - 现金流量表

贝瑞基因

(000710)

  

流通市值:40.63亿  总市值:43.59亿
流通股本:3.30亿   总股本:3.54亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金759,679,533.2485,524,295.91236,129,690.91,150,398,015.72
  收到的税费返还3,388,626.123,388,626.123,387,678.09350,641.82
  收到其他与经营活动有关的现金4,227,870.382,872,499.61,638,468.755,795,003.69
  经营活动现金流入小计767,296,029.7491,785,421.63241,155,837.741,156,543,661.23
  购买商品、接受劳务支付的现金421,184,452.67274,648,805.43148,595,050.59520,349,424.37
  支付给职工以及为职工支付的现金240,832,669.78163,134,578.2779,254,113.66322,893,191.11
  支付的各项税费36,091,944.7320,631,683.157,955,587.7863,934,945.15
  支付其他与经营活动有关的现金93,769,793.4165,272,787.0139,944,476.97161,396,178.89
  经营活动现金流出小计791,878,860.59523,687,853.86275,749,2291,068,573,739.52
  经营活动产生的现金流量净额-24,582,830.89-31,902,432.23-34,593,391.2687,969,921.71
二、投资活动产生的现金流量:
  收回投资收到的现金9,502,364.169,502,364.16--
  处置固定资产、无形资产和其他长期资产收回的现金净额6,060,992.232,226,3002,222,300421,040,811.45
  收到的其他与投资活动有关的现金---12,344,515.56
  投资活动现金流入小计15,563,356.3911,728,664.162,222,300433,385,327.01
  购建固定资产、无形资产和其他长期资产支付的现金63,345,002.436,941,835.412,560,779.9756,754,406.14
  投资支付的现金6,476,810.292,222,2002,222,200171,500,000
  支付其他与投资活动有关的现金---14,700,000
  投资活动现金流出小计69,821,812.6939,164,035.414,782,979.97242,954,406.14
  投资活动产生的现金流量净额-54,258,456.3-27,435,371.24-12,560,679.97190,430,920.87
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,020,000---
  取得借款收到的现金172,848,975.65149,260,233.4326,700,000123,296,255.68
  收到其他与筹资活动有关的现金---1,086,400
  筹资活动现金流入小计174,868,975.65149,260,233.4326,700,000124,382,655.68
  偿还债务支付的现金133,696,255.6899,996,255.6815,020,684.35296,793,968.69
  分配股利、利润或偿付利息支付的现金3,462,275.212,120,005.721,002,932.718,692,207.51
  支付其他与筹资活动有关的现金14,572,959.644,986,669.64-56,744,561.64
  筹资活动现金流出小计151,731,490.53107,102,931.0416,023,617.06362,230,737.84
  筹资活动产生的现金流量净额23,137,485.1242,157,302.3910,676,382.94-237,848,082.16
四、汇率变动对现金及现金等价物的影响-2,058,048.65-2,104,346.99-505,136.481,631,167.18
五、现金及现金等价物净增加额-57,761,850.72-19,284,848.07-36,982,824.7742,183,927.6
  加:期初现金及现金等价物余额358,312,814.14358,312,814.14358,312,814.14316,128,886.54
  期末现金及现金等价物余额300,550,963.42339,027,966.07321,329,989.37358,312,814.14
补充资料:
  净利润--25,410,162.78--188,175,034.28
  资产减值准备---28,078,288.63
  固定资产和投资性房地产折旧-31,805,648.17-74,182,104.23
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-31,805,648.17-74,182,104.23
  无形资产摊销-2,144,195.36-3,008,323.22
  长期待摊费用摊销-5,559,091.7-8,359,791.23
  处置固定资产、无形资产和其他长期资产的损失-11,541.91--1,739,687.32
  固定资产报废损失-142,109.7-500,043.53
  公允价值变动损失--2,203,689.24-132,165.22
  财务费用-5,513,610-10,403,903.76
  投资损失--3,257,567.49-14,553,527.69
  递延所得税--645,625.53-5,326,667.64
  其中:递延所得税资产减少--1,596,055.68-7,197,424.69
    递延所得税负债增加-950,430.15--1,870,757.05
  存货的减少-2,078,244.8-31,951,607.53
  经营性应收项目的减少-52,344,486.74--16,688,541.53
  经营性应付项目的增加--125,769,315.32--30,297,511.01
  其他---633,871.22
  现金的期末余额-339,027,966.07-358,312,814.14
  减:现金的期初余额-358,312,814.14-316,128,886.54
  现金及现金等价物的净增加额--19,284,848.07-42,183,927.6
公告日期2025-10-312025-08-302025-04-282025-04-25
审计意见(境内)标准无保留意见
TOP↑